Waypoint swoops for Euromedic
This article was originally published in Clinica
Waypoint Capital will assume full ownership of medical services provider Euromedic International after agreeing to buy shares owned by Montagu Private Equity. Waypoint was previously the majority holder of Euromedic through its investment partnership, Ares Life Sciences. Budapest, Hungary-based Euromedic is the leading provider of advanced diagnostic imaging and cancer care services in Europe, according to Waypoint, and owns and operates 144 centers across 14 countries. Euromedic has been honing its focus in these areas, and in 2011 sold its International Dialysis Centers unit to Fresenius. Euromedic services both public patients funded by National Health Funds as well as private patients funded by Private Health Insurance or by the patient directly. No financial details of the deal were given.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.